Lyka Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE933A01014
  • NSEID: LYKALABS
  • BSEID: 500259
INR
83.01
1.97 (2.43%)
BSENSE

Dec 05

BSE+NSE Vol: 2.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Trident Lifeline
Gennex Lab.
Bafna Pharma.
Sanjiv.Parant.
Brooks Lab.
Zenotech Lab.
Lyka Labs
Valiant Laborato
Zim Laboratories
Oxygenta Pharma
Sat Kartar
Why is Lyka Labs Ltd ?
1
High Debt Company with a Debt to Equity ratio (avg) at 2.98 times
  • Poor long term growth as Net Sales has grown by an annual rate of 14.82% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 2.98 times
  • PBT LESS OI(Q) At Rs -5.47 cr has Fallen at -307.20%
  • PAT(Q) At Rs -3.36 cr has Fallen at -260.0%
  • NET SALES(Q) At Rs 36.66 cr has Fallen at -10.93%
2
Below par performance in long term as well as near term
  • Along with generating -49.78% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lyka Labs for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Lyka Labs
-49.78%
-1.41
35.35%
Sensex
4.56%
0.38
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.82%
EBIT Growth (5y)
37.47%
EBIT to Interest (avg)
1.52
Debt to EBITDA (avg)
3.43
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.94
Tax Ratio
29.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.84%
ROCE (avg)
16.68%
ROE (avg)
47.42%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
141
Industry P/E
34
Price to Book Value
2.84
EV to EBIT
108.63
EV to EBITDA
30.41
EV to Capital Employed
2.41
EV to Sales
2.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.22%
ROE (Latest)
2.02%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-12What is not working for the Company
PBT LESS OI(Q)

At Rs -5.47 cr has Fallen at -307.20%

PAT(Q)

At Rs -3.36 cr has Fallen at -260.0%

NET SALES(Q)

At Rs 36.66 cr has Fallen at -10.93%

PBDIT(Q)

Lowest at Rs -2.54 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -6.93%

EPS(Q)

Lowest at Rs -0.94

Loading Valuation Snapshot...
Here's what is not working for Lyka Labs
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -5.47 cr has Fallen at -307.20%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -3.36 cr has Fallen at -260.0%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 36.66 cr has Fallen at -10.93%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -2.54 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -6.93%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -5.47 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -0.94
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Non Operating Income - Quarterly
Highest at Rs 1.09 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income